人物經歷
1995年在中國藥科大學獲中藥製劑專業學士學位, 1998年在中國藥科大學獲藥理學碩士學位,2002年在中國藥科大學獲藥理學博士學位。1998年7月至1999年8月於香港聯邦製藥廠有限公司新藥研發部工作。2003年3月至2005年4月於南京師範大學生命科學院博士後流動站進行博士後研究工作。2005年6月晉升為南京師範大學副教授並留校任教。2013.3至2014.3於美國密西根大學進行訪學研究。
研究領域
目前主要從事的基礎研究方向為:1 G蛋白及GPCR(G蛋白耦聯受體)對炎症信號轉導網路的調控 2 RGS(G蛋白信號調節蛋白)對GPCR的調控作用及對免疫應激反應和腫瘤發生的影響 3 YAP(Yes相關蛋白)對炎症及腫瘤信號通路的調節作用 4 YAP與腫瘤耐藥性的關係 5 RGS、GPCR、YAP對氣體信號分子信號通路的干預作用
套用研究的方向有:1. 新型非甾體抗炎藥物的合成、生物活性及作用機制研究。2.抗腫瘤藥物的研究:具有光敏動力學特性的新型抗癌藥物的合成及生物活性研究;以RGS、GPCR、YAP為靶點的抗腫瘤天然產物或化合物的研發。3.小分子抗炎或抗腫瘤藥物的構效關係研究及結構最佳化。
學術成果
先後參與或主持國家重大科技專項“新藥創製”兩項、國家自然科學基金項目、江蘇省自然科學基金項目、動物學國家重點學科培育點“創新基金”項目等多項課題,承擔企事業單位委託項目多項。已發表學術論文50餘篇,其中SCI收錄近20篇(其中一區1篇,二區6篇),總影響因子達40餘分,並申請發明專利6項。
近年代表性論文:
1 Jing Cheng, Yifang Du, Lin Huan, Lili Pan, Wei Li, Zhunan Gong, Shaohua Wei, Shiqian Huang, Yi Zhang, Wei Xun, Leilei Chang, Mengyu Xie, Guizhen Ao, Jie Cai, Ting Qiu, Hao Wu, Ting Sun, Guanglin Xu. Growth inhibitory effect of KYKZL-1 on Hep G2 cells via inhibition of AA metabolites and caspase-3 pathway and cell cycle arrest. Toxicology and applied pharmacology, 2014,274(1):96-106. (通訊作者,SCI,二區,5-year average IF 4.117).
2 Xu GL, Du YF, Cheng J, Huan L, Chen SC, Wei SH, Gong ZN, Cai J, Qiu T, Wu H, Sun T, Ao GZ. Inhibition of inflammatory mediators contributes to the anti-inflammato ry activity of KYKZL-1 via MAPK and NF-κB pathway. Toxicology and applied pharmacology, 2013, 272(1) :221-9. (SCI,二區,5-year average IF 4.117)
3 Guanglin Xu, Guang Li, Huaping Ma, Hai Zhong, Fei Liu and Guizhen Ao.Preventive Effect of Crocin in Inflamed Animals and in LPS-Challenged RAW 264.7 Cells.Journal of Agricultural and Food Chemistry, 2009, 57:8325–8330. (SCI,一區)
4 Guanglin Xu, Fei Liu, Guizhen Ao, Shuying He, Min Ju, Yue Zhao, Ting Xue. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor. European Journal of Pharmacology, 2009,611:100-106. (SCI)
5 Guanglin Xu, Fei Liu, Yue Zhao, Guizhen Ao, Liang Xi, Min Ju, Ting Xue. Biological Evaluation of 2-(4-Amino-Phenyl) -3-(3,5- Dihydroxyl phenyl) Propenoic Acid. Basic & Clinical Pharmacology & Toxicology, 2009,105(5):350-6. (SCI).
6 Guanglin Xu, Zhunan Gong, Weiping Yu, Lei Gao, Shuying He, and Zhiyu Qian. Increased Expression Ratio of bcl-2/bax Is Asssociated with Crocin-mediated Apoptosis in Bovine Aortic Endothelial Cells. Basic & Clinical Pharmacology & Toxicology, 2007,100,(1):31-35. (SCI)
7 Guanglin Xu, Lin Yao, Z.hunan Gong, Shuangquan Zhang, Shuqin Yu. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. Journal of Ethnopharmacology, 2005, 98(1-2):177-183. (SCI)
8 Guanglin Xu, Zhiyu Qian, Shuqin Yu,Zhunan Gong, Xiangchun Shen. Evidence of crocin against endothelial injury induced by hydrogen peroxide in vitro. Journal of Asian Natural Products Research,2006, 8(1-2):79-85. (SCI).
9 Yan T, Li Q, Zhou H, Zhao Y, Yu S, Xu G, Yin Z, Li Z, Zhao Z. Gu-4 suppresses affinity and avidity modulation of CD11b and improves the outcome of mice with endotoxemia and sepsis. PLoS One,2012,7(2): e30110. ((SCI, 二區, IF 4.4))
10 Li C, Zhang H, Wu P, Gong Z, Xu G, Cai C.Electrochemical detection of extracellular hydrogen peroxide released from RAW 264.7 murine macrophage cells based on horseradish peroxidase-hydroxyapatite nanohybrids. Analyst,2011, 136(6):1116-23. (SCI, 二區, IF 4.23)
11 Li L, Rui X, Liu T, Xu G, He S. Effect of heparin-derived oligosaccharide on vascular smooth muscle cell proliferation and the signal transduction mechanisms involved. Cardiovasc Drugs Ther, 2012, 26(6): 479-88. (SCI, IF 3.1)
12 Li L, Li W, Ren Z, He S, Xu G, Yang L. Effect of heparin-derived oligosaccharide on vascular smooth muscle cell proliferation. Vasc Endovascular Sur, 2012, 46(5): 393-400. (SCI)
13 Liang Xi, Zhiyu Qian, Guanglin Xu, Shuguo Zheng, Sai Sun, Na Wen, Liang Sheng, Yun Shi, Yabing Zhang. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. Journal of Nutritional Biochemistry, 2007,18:64-72. (SCI, 二區, IF 3.5).
14 Zhiyu Qian, Liang Xi, Guanglin Xu, Chenghua Zhou, and Sai Sun. Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-a and adiponectin expression in rat adipocytes. British Journal of Pharmacology, 2007,151(5):610-617. (SCI, 二區, IF 3.8).
15 Shuying He, Zhiyu Qian, Futian Tang, Na Wen, Guanglin Xu, Liang Sheng. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sciences, 2005,77(8):907-921. (SCI).
16 Shuying He, Zhiyu Qian, Na Wen, Futian Tang, Guanglin Xu. Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. European Journal of Pharmacology. 2007,554,191-195. ( SCI).
17 Guanglin Xu, Zhunan Gong. The 3rd International Conference on Natural Products Development. 《Natural Products- Essential Resource for Human Survival》: Protective effect of crocin on rat heart ischemia-reperfusion injury and possible mechanisms. World Scientific,2007,February.(世界科學出版社,新加坡).
榮譽獎項
個人及課題組多次獲獎,主要有:中法藥理聯合會頒發的“中法斯維雅(Servier)青年藥理學工作者獎”“南京市第七屆自然科學優秀學術論文獎”“優秀中青年骨幹教師”“優秀博士後”等。